Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

1.

[Changes in the free-radical state and level of free iron during the formation of drug resistance in tumor cells].

Saprin AN, Kalinina EV, Serezhenkov VA, Kotova IaN, Solomka VS, Shcherbak NP.

Biofizika. 2006 May-Jun;51(3):485-90. Russian.

PMID:
16808348
[PubMed - indexed for MEDLINE]
2.

[Role of the antioxidant system and redox-dependent regulation of transcription factors bcl-2 and p53 in forming resistance of human K562 erythroleukemia cells to doxorubicin].

Kalinina EV, Saprin AN, Solomka VS, Shcherbak NP, Chermnykh NS, Piruzian LA.

Vopr Onkol. 2001;47(5):595-600. Russian.

PMID:
11785103
[PubMed - indexed for MEDLINE]
4.

Changes in expression of genes encoding antioxidant enzymes, heme oxygenase-1, Bcl-2, and Bcl-xl and in level of reactive oxygen species in tumor cells resistant to doxorubicin.

Kalinina EV, Chernov NN, Saprin AN, Kotova YN, Andreev YA, Solomka VS, Scherbak NP.

Biochemistry (Mosc). 2006 Nov;71(11):1200-6.

PMID:
17140381
[PubMed - indexed for MEDLINE]
5.

Paramagnetic species in the plasma of dogs with lymphoma prior to and after treatment with doxorubicin. An ESR study.

Gille L, Kleiter M, Willmann M, Nohl H.

Biochem Pharmacol. 2002 Dec 15;64(12):1737-44.

PMID:
12445862
[PubMed - indexed for MEDLINE]
6.

[Interaction between dinitrosyl iron complexes and intermediate products of oxidative stress].

Shumaev KB, Gubkin AA, Gubkina SA, Gudkov LL, Sviriaeva IV, Timoshin AA, Topunov AF, Vanin AF, Ruuge EK.

Biofizika. 2006 May-Jun;51(3):472-7. Russian.

PMID:
16808346
[PubMed - indexed for MEDLINE]
7.

Development and characterization of P-glycoprotein 1 (Pgp1, ABCB1)-mediated doxorubicin-resistant PLHC-1 hepatoma fish cell line.

Zaja R, Caminada D, Loncar J, Fent K, Smital T.

Toxicol Appl Pharmacol. 2008 Mar 1;227(2):207-18. Epub 2007 Nov 13.

PMID:
18076962
[PubMed - indexed for MEDLINE]
8.

Induction of tumor-specific cytotoxicity and apoptosis by doxorubicin.

Suzuki F, Hashimoto K, Kikuchi H, Nishikawa H, Matsumoto H, Shimada J, Kawase M, Sunaga K, Tsuda T, Satoh K, Sakagami H.

Anticancer Res. 2005 Mar-Apr;25(2A):887-93.

PMID:
15868924
[PubMed - indexed for MEDLINE]
Free Article
9.

[Reversal of multidrug resistance by MDR1 shRNA expression vector in human leukemia K562/A02 cells].

Xiao XB, Xie ZX, Qin Q.

Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):422-5. Chinese.

PMID:
17152486
[PubMed - indexed for MEDLINE]
10.

Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.

Wu J, Lu Y, Lee A, Pan X, Yang X, Zhao X, Lee RJ.

J Pharm Pharm Sci. 2007;10(3):350-7.

PMID:
17727798
[PubMed - indexed for MEDLINE]
Free Article
11.

[Why does iron abrogate the cytotoxic effect of S-nitrosothiols on human and animal cultured cells?].

Serezhenkov VA, Kalinina EV, Glazunova VA, Saprin AN, Vanin AF.

Biofizika. 2007 Sep-Oct;52(5):869-75. Russian.

PMID:
17969921
[PubMed - indexed for MEDLINE]
12.

GSH-dependent redox regulation and antioxidant enzymes in the formation of resistance to doxorubicin in K562 human erythroleukemia cells.

Kalinina E, Novichkova M, Scherbak NP, Solomka V, Saprin AN.

Adv Exp Med Biol. 2001;500:241-4. No abstract available.

PMID:
11764946
[PubMed - indexed for MEDLINE]
13.

Interactions between doxorubicin and the human iron regulatory system.

Brazzolotto X, Andriollo M, Guiraud P, Favier A, Moulis JM.

Biochim Biophys Acta. 2003 Feb 17;1593(2-3):209-18.

PMID:
12581865
[PubMed - indexed for MEDLINE]
Free Article
14.

Evidence for human liver mediated free-radical formation by doxorubicin and mitozantrone.

Basra J, Wolf CR, Brown JR, Patterson LH.

Anticancer Drug Des. 1985 Oct;1(1):45-52.

PMID:
2835961
[PubMed - indexed for MEDLINE]
16.

Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.

Li X, Sun B, Zhu CJ, Yuan HQ, Shi YQ, Gao J, Li SJ, Lou HX.

Toxicol In Vitro. 2009 Feb;23(1):29-36. doi: 10.1016/j.tiv.2008.09.015. Epub 2008 Oct 1.

PMID:
18938236
[PubMed - indexed for MEDLINE]
17.

Dinitrosyl iron complexes bind with hemoglobin as markers of oxidative stress.

Shumaev KB, Kosmachevskaya OV, Timoshin AA, Vanin AF, Topunov AF.

Methods Enzymol. 2008;436:445-61. doi: 10.1016/S0076-6879(08)36025-X.

PMID:
18237648
[PubMed - indexed for MEDLINE]
18.

Iron-mediated formation of an oxidized adriamycin free radical.

Zweier JL.

Biochim Biophys Acta. 1985 Apr 17;839(2):209-13.

PMID:
2985121
[PubMed - indexed for MEDLINE]
19.

[Inhibition of hydrogen peroxide, oxygen and semiquinone radicals in the development of drug resistance to doxorubicin in human erythroleukemia K562-cells].

Kalishina EV, Saprin AN, Solomka VS, Shchebrak NP, Piruzian LA.

Vopr Onkol. 2003;49(3):294-8. Review. Russian. No abstract available.

PMID:
12926210
[PubMed - indexed for MEDLINE]
20.

Indomethacin overcomes doxorubicin resistance by decreasing intracellular content of glutathione and its conjugates with decreasing expression of gamma-glutamylcysteine synthetase via promoter activity in doxorubicin-resistant leukemia cells.

Asano T, Tsutsuda-Asano A, Fukunaga Y.

Cancer Chemother Pharmacol. 2009 Sep;64(4):715-21. doi: 10.1007/s00280-008-0920-6. Epub 2009 Jan 20.

PMID:
19153736
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk